Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia

The clinical diagnosis of vascular dementia (VaD) is based on imaging criteria, and specific biochemical markers are not available. Here, we investigated the potential of cerebrospinal fluid (CSF) lipocalin 2 (LCN2), a secreted glycoprotein that has been suggested as mediating neuronal damage in vas...

Descripción completa

Detalles Bibliográficos
Autores principales: Llorens, Franc, Hermann, Peter, Villar-Piqué, Anna, Diaz-Lucena, Daniela, Nägga, Katarina, Hansson, Oskar, Santana, Isabel, Schmitz, Matthias, Schmidt, Christian, Varges, Daniela, Goebel, Stefan, Dumurgier, Julien, Zetterberg, Henrik, Blennow, Kaj, Paquet, Claire, Baldeiras, Inês, Ferrer, Isidro, Zerr, Inga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992814/
https://www.ncbi.nlm.nih.gov/pubmed/32001681
http://dx.doi.org/10.1038/s41467-020-14373-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992814/
https://www.ncbi.nlm.nih.gov/pubmed/32001681
http://dx.doi.org/10.1038/s41467-020-14373-2

Ejemplares similares